Shandong Bailong Chuangyuan Bio-Tech Co Ltd. Stock Analysis 605016.SS

Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. engages in the research & development, production and sales of prebiotic series products, dietary fiber series products, starch sugar series and healthy sweetener products. The company is headquartered in Dezhou, Shandong and currently employs 990 full-time employees. The company went IPO on 2021-04-21. The firm focuses on the research, development, production, and sales of prebiotic series products, dietary fiber series products, healthy sweetener series products, and other starch sugar (alcohol) products. The firm's main products include isomaltooligosaccharide, fructooligosaccharide, galactooligosaccharide, xylooligosaccharide, resistant dextrin, polydextrose, allulose, isomaltulose, stachyose, and crystalline fructose. The firm's products are mainly used as food ingredients in food, beverages, dairy products, frozen foods, baked goods, infant formula, and health products. The firm mainly conducts its business in the domestic and overseas markets.